Company intelligence / Profile preview

PrimeStone Capital

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

PrimeStone Capital is a London-based investment management firm focused on public equity investing and shareholder engagement rather than drug development, healthcare products, or life sciences services. The firm is regulated in the United Kingdom and operates as an alternative investment fund manager providing discretionary investment management and portfolio management services. Public materials emphasize long-term ownership, operational improvement, strategy, and engagement with portfolio companies. Based on available evidence, PrimeStone Capital is a financial services company, not a biotech, pharma, medtech, CRO, or other healthcare operating company.

Industry: Investors

Beyond the preview

Go deeper on PrimeStone Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrimeStone Capital.

Explore the full profile